LivaNova PLC

LIVN69

High Quality

$52.32arrow_drop_down2.57%-$1.37

High Quality

LIVN69

$52.32

arrow_drop_down2.57%-$1.37

High Quality

Performance History

Key Stats
Open	$53.55
Prev. Close	$53.58
EPS	0.43
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	51.70	55.10
52 Week Range	42.75	64.47

Ratios







EPS	0.43

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About LivaNova PLC (LIVN)

LivaNova PLC is a global medical technology company that operates in the fields of cardiovascular and neuromodulation therapies. The company focuses on delivering innovative and effective solutions for patients with life-threatening diseases. LivaNova's cardiovascular therapies include products for cardiac surgery, including heart valves, surgical ablation systems, and cannulae. In the neuromodulation field, the company offers a range of products for treating epilepsy, depression, and other neurological disorders. With a strong commitment to research and development, LivaNova is constantly seeking to improve patient outcomes and advance medical technology.

LivaNova PLC's stock price history shows a steady upward trend over the past few years. From 2016 to 2020, the stock price increased from around $50 per share to over $100 per share. This growth can be attributed to the company's successful product launches, strong financial performance, and favorable market conditions. Despite the impact of the COVID-19 pandemic on the healthcare industry, LivaNova has managed to maintain its growth trajectory and generate positive returns for its shareholders.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. William A. Kozy
Headquarters: London
Employees: 2900
Exchange: NASDAQ

Keep an eye on LivaNova PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is LivaNova PLC's (LIVN) price per share?

The current price per share for LivaNova PLC (LIVN) is $52.32. The stock has seen a price change of -$1.38 recently, indicating a -2.58% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for LivaNova PLC (LIVN)?

For LivaNova PLC (LIVN), the 52-week high is $64.48, which is 23.23% from the current price. The 52-week low is $42.75, the current price is 22.39% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is LivaNova PLC (LIVN) a growth stock?

LivaNova PLC (LIVN) has shown an average price growth of -3.55% over the past three years. It has received a score of 32 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying LivaNova PLC as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is LivaNova PLC (LIVN) stock price performance year to date (YTD)?

As of the latest data, LivaNova PLC (LIVN) has a year-to-date price change of 3.52%. Over the past month, the stock has experienced a price change of -2.78%. Over the last three months, the change has been 18.29%. Over the past six months, the figure is -14.43%. Looking at a longer horizon, the five-year price change stands at -31.71%.

help

Is LivaNova PLC (LIVN) a profitable company?

LivaNova PLC (LIVN) has a net income of $17.55M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.09% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 14.09% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.15B, with a revenue growth rate of 12.89%, providing insight into the company's sales performance and growth. The gross profit is $785.45M. Operating income is noted at -$68.5M. Furthermore, the EBITDA is $175.15M.

help

What is the market capitalization of LivaNova PLC (LIVN)?

LivaNova PLC (LIVN) has a market capitalization of $2.91B. The average daily trading volume is 52.73, indicating the stock's liquidity and investor engagement.

News

BLOOD RECOVERY MACHINE

MEDICAL TECHNOLOGY

AUTOLOGOUS BLOOD TRANSFUSION

SURGICAL PROCEDURES

Nov 11, 2024

Blood Recovery Machine Market is expected to reach revenue of USD 4,277.4 Mn by 2033, at 5.9% CAGR: Dimension Market Research.

TECHNOLOGY ADVANCEMENTS

Sep 17, 2024

Global Electrotherapy System Research Report 2024: A $1.65 Billion Market by 2030 - TENS Segment Dominates as Demand for Chronic Pain Management Grows

CARDIOVASCULAR SURGERY DEVICES

BEATING HEART SURGERY SYSTEMS

PERFUSION DISPOSABLES

UNITED STATES MARKET

Sep 16, 2024

United States Cardiovascular Surgery Devices Market Outlook to 2033: Focus on Beating Heart Surgery Systems and Perfusion Disposables

CMR Surgical appoints Daniel Moore as Non-Executive Chairman - GlobeNewswire